stanozolol has been researched along with Menopause in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baylink, DJ; Chesnut, CH; Gruber, HE; Ivey, JL; Matthews, M; Nelp, WB; Sisom, K | 1 |
| Applebaum-Bowden, D; Foster, DM; Haffner, SM; Hazzard, WR; Kushwaha, RS | 1 |
| Chesnut, CH | 1 |
| Albers, JJ; Applebaum-Bowden, D; Chestnut, CH; Cheung, MC; Haffner, S; Hazzard, WR; Taggart, HM; Warnick, GR | 1 |
| Baylink, DJ; Burnell, JM; Chesnut, CH; Teubner, EJ | 1 |
2 trial(s) available for stanozolol and Menopause
| Article | Year |
|---|---|
Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.
Topics: Aged; Bone and Bones; Calcium; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Menopause; Middle Aged; Osteoporosis; Radiography; Stanozolol | 1983 |
The role of skeletal calcium deficiency in postmenopausal osteoporosis.
Topics: Bone and Bones; Calcitonin; Calcium; Calcium, Dietary; Clinical Trials as Topic; Female; Humans; Menopause; Minerals; Osteoporosis; Stanozolol; Vitamin D | 1986 |
3 other study(ies) available for stanozolol and Menopause
| Article | Year |
|---|---|
Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogens; Female; Humans; Kinetics; Lipase; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Models, Biological; Stanozolol | 1984 |
Treatment of postmenopausal osteoporosis: some current concepts.
Topics: Aged; Calcitonin; Calcium Carbonate; Clodronic Acid; Ergocalciferols; Estrogens; Female; Humans; Menopause; Methandrostenolone; Middle Aged; Osteoporosis; Physical Exertion; Sodium Fluoride; Stanozolol | 1981 |
Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis.
Topics: Aged; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Lipase; Lipoprotein Lipase; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Osteoporosis; Stanozolol | 1982 |